Myelodysplasia From Valproic Acid Resolved by Cessation
Chidiebube Ugwu, Angimar Uriepero Palma, Rekha Bhat, Alankrita Taneja · 2026
Read Myelodysplasia From Valproic Acid Resolved by Cessation by Chidiebube Ugwu, Angimar Uriepero Palma, Rekha Bhat, Alankrita Taneja (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473839.txt.
Description
Myelodysplastic neoplasms (MDS) are clonal blood disorders that cause ineffective hematopoiesis, low blood counts, and a risk of progression to acute myeloid leukemia. Chemotherapy and radiation usually drive these changes, but a small set of medications, including valproic acid (VPA), can also produce reversible myelodysplastic features.
Catalog record
| CREATOR | Chidiebube Ugwu, Angimar Uriepero Palma, Rekha Bhat, Alankrita Taneja |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |